EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Prognostic role of tumour volume and downstaging response on outcome after liver transplantation for colorectal liver metastases: retrospective study

Håvard Bjørke Jenssen iD, Svein Dueland iD, Tor Magnus Smedman iD, Harald Grut, Andreas Abildgaard, Pål D Line iD, Trygve Syversveen

BJS Open · 2025

DOI: 10.1093/bjsopen/zraf170 ↗

Kurz gefasst

Fachartikel in der Zeitschrift BJS Open, 2025. Verfasst von Håvard Bjørke Jenssen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Radiology and Nuclear Medicine, Oslo University Hospital, Oslo, Norway. Hauptthemen laut MEDLINE: Liver Neoplasms, Colorectal Neoplasms, Liver Transplantation, Tumor Burden. Die Arbeit nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: South-Eastern Norway Health Authority, Norwegian Cancer Society.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The incidence of colorectal cancer is increasing, and the liver remains the predominant site for metastases. Whereas liver resection is the standard treatment for colorectal liver metastases (CRLMs), liver transplantation (LT) has re-emerged as a viable option for selected patients. The aim of this study was to investigate whether tumour volume and changes in tumour volume during chemotherapy before transplantation predict overall survival.

Methods

Patients who underwent LT for CRLMs between November 2006 and August 2020 were included. Tumour volumes were measured via manual segmentation on computerized tomography scans at baseline, at maximum tumour volume, and immediately before LT. Response to chemotherapy was assessed using Response Evaluation Criteria in Solid Tumours (RECIST) criteria, and the heterogeneous response was noted to investigate whether this subgroup performs differently. Receiver operating characteristic analysis was conducted to determine a tumour volume cut-off value for predicting overall survival. Overall survival between groups was compared using Kaplan–Meier curves and log rank test.

Results

Fifty-nine patients who underwent LT for CRLMs were analysed retrospectively. Receiver operating characteristic analysis revealed that final tumour volume at time of LT was a strong predictor of 5-year overall survival (area under the curve= 0.789), with a 35 mL cut-off providing optimal clinical discrimination. Patients achieving a final tumour volume below 35 mL, either consistently or via downstaging, demonstrated significantly improved survival compared with those with persistently high tumour volumes (4.54 years versus 2.17 years; P < 0.001). Heterogeneous responses to chemotherapy were associated with poorer prognosis with no patients surviving beyond 2.16 years (P < 0.001).

Conclusion

Dynamic tumour assessment, particularly measuring tumour volume to below 35 mL, is an important prognostic marker in LT for CRLMs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver NeoplasmsColorectal NeoplasmsLiver TransplantationTumor BurdenHumansRetrospective StudiesFemaleMalePrognosisMiddle AgedNeoplasm StagingAgedROC CurveTomography, X-Ray ComputedTreatment OutcomeKaplan-Meier EstimateAdult

Stichwörter der Autor:innen

hepatic recurrencemultimodal treatmentoverall survivalradiological responsesurvival predictorstransplant eligibility

Autor:innen und Institutionen

  • Division of Radiology and Nuclear Medicine, Oslo University Hospital, Oslo, Norway.
  • Transplant Oncology Research Group, Division of Surgery and Specialized Medicine, Oslo University Hospital, Oslo, Norway.
  • Department of Oncology, Oslo University Hospital, Oslo, Norway.
  • Department of Radiology, Vestre Viken Hospital Trust, Drammen, Norway.
  • Section for Transplant Surgery, Department of Transplantation Medicine, Oslo University Hospital, Oslo, Norway.
  • Institute of Clinical Medicine, University of Oslo, Oslo, Norway.

ORCID-Profile: Håvard Bjørke Jenssen, Svein Dueland, Tor Magnus Smedman, Pål D Line

Förderung

  • South-Eastern Norway Health Authority
  • Norwegian Cancer Society

Zitieren

APA

Jenssen, H. B., Dueland, S., Smedman, T. M., Grut, H., Abildgaard, A., Line, P. D., & Syversveen, T. (2025). Prognostic role of tumour volume and downstaging response on outcome after liver transplantation for colorectal liver metastases: retrospective study. BJS Open. https://doi.org/10.1093/bjsopen/zraf170

Vancouver

Jenssen HB, Dueland S, Smedman TM, Grut H, Abildgaard A, Line PD, et al. Prognostic role of tumour volume and downstaging response on outcome after liver transplantation for colorectal liver metastases: retrospective study. BJS Open. 2025. doi:10.1093/bjsopen/zraf170

BibTeX
@article{Jenssen2025,
  author = {Jenssen, Håvard Bjørke and Dueland, Svein and Smedman, Tor Magnus and Grut, Harald and Abildgaard, Andreas and Line, Pål D and Syversveen, Trygve},
  title = {Prognostic role of tumour volume and downstaging response on outcome after liver transplantation for colorectal liver metastases: retrospective study},
  journal = {BJS Open},
  year = {2025},
  doi = {10.1093/bjsopen/zraf170}
}
Kostenlos starten →